Open AccessTransmission blocking vaccine studies in leishmaniasis: I Lipophosphogly can is a promising transmission blocking vaccine molecule against cutaneous leishmaniasis
Author(s) -
WK Tonui,
Mbati Pa,
Anjili Co,
Orago As,
Turco Sj,
Githure Ji,
Koech Dk
Publication year - 2001
Publication title -
east african medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.102
H-Index - 40
ISSN - 0012-835X
DOI - 10.4314/eamj.v78i2.9094
Subject(s) - phlebotomus , leishmania , leishmaniasis , psychodidae , cutaneous leishmaniasis , antigen , vector (molecular biology) , leishmania major , virology , biology , lutzomyia , transmission (telecommunications) , immunology , parasite hosting , microbiology and biotechnology , recombinant dna , biochemistry , electrical engineering , engineering , world wide web , computer science , gene
New strategies for control of leishmaniasis is needed as chemotherapy using antimonial drugs is prolonged, expensive, associated with side effects and relapses. Vector control has limitations and a vaccine which may be the best approach is not available.